Opaleye Management is an investment Firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 5, 2021
IpiNovyx Bio
|
Seed | $10M | Biotechnology | — |
Apr 20, 2021
Tesseract Health
|
Series B | $80M | Health Care | — |
Apr 8, 2021
ValenzaBio
|
Series A | $79.37M | Biopharma | — |
May 28, 2020
Palvella Therapeutics
|
Series C | $45M | Biotechnology | — |
Aug 8, 2019
Stereotaxis
|
Post-IPO Equity | $25M | Biotechnology | — |
Opaleye Management has had 4 exits. Opaleye Management most notable exits include ValenzaBio , Acutus Medical
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 5, 2023 | ValenzaBio | M&A | Biopharma | Detail |
Aug 5, 2020 | Acutus Medical | IPO | Biotechnology | Detail |
Aug 4, 2016 | Stereotaxis | IPO | Biotechnology | Detail |
Dec 28, 2015 | Ekso Bionics | IPO | Medical Device | Detail |